• Mifepristone (RU486) in Precision Oncology: Mechanism, Proto

  2026-04-30

  Discover the advanced mechanistic landscape of Mifepristone (RU486) as a research tool in oncology, reproductive biology, and beyond. This article explores novel protocol guidance, cross-talk with neuroendocrine cytochrome P450 regulation, and unique assay implications to inform your next experiment.

• SARS-CoV-2 Nucleocapsid Protein Disrupts GADD34-Mediated Imm

  2026-04-29

  This study uncovers how the SARS-CoV-2 nucleocapsid protein antagonizes host innate immunity by sequestering GADD34 mRNA in atypical stress granule-like foci, impairing IRF3 nuclear localization and downstream interferon production. These mechanistic insights illuminate novel viral evasion strategies and suggest new molecular targets for modulating antiviral responses.

• EGCG Nanoparticles Enhance FLASH-RT Efficacy via DNA Damage

  2026-04-29

  This study demonstrates that functionalized EGCG nanoparticles (BENPs) significantly enhance the antitumor effects of ultra-high dose rate radiotherapy (FLASH-RT) by promoting DNA double-strand breaks and modulating the immune microenvironment. The findings highlight a potent strategy for improving cancer radiotherapy outcomes through radiosensitization and immune activation.

• Neuroligin 1 Proteolysis Sustains Social Memory via Cofilin

  2026-04-28

  Liu et al. reveal that proteolytic fragments of neuroligin 1, generated by social interaction, are crucial for maintaining social memory through cofilin signaling in the ventral hippocampus. These findings connect synaptic structural remodeling with the persistence of social and novel object memories, providing new molecular insights into cognitive disorders.

• Filipin III: Precision Cholesterol Detection in Membranes

  2026-04-28

  Filipin III, a polyene macrolide antibiotic, is the benchmark for precise cholesterol detection in biological membranes. Its specificity and compatibility with advanced imaging workflows empower researchers to map cholesterol-rich microdomains and decipher immunometabolic mechanisms in health and disease.

• Dextrose (D-glucose): Precision Workflows for Metabolic Rese

  2026-04-27

  Dextrose (D-glucose) from APExBIO empowers metabolic pathway, immunometabolism, and diabetes research with unmatched purity and solubility. Discover optimized protocols, troubleshooting strategies, and actionable insights to achieve reproducible, high-sensitivity data in cell-based and biochemical assays.

• Practical Use of Prestained Protein Marker (Triple color, ED

  2026-04-27

  The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) is designed for unambiguous molecular weight estimation and transfer verification in SDS-PAGE and Western blotting workflows. It is particularly suitable for protocols requiring phosphoprotein compatibility or fluorescent membrane imaging, but should not be used where EDTA or unstained markers are specifically required. Its clear banding pattern and ready-to-use format streamline routine QC and troubleshooting.

• BH3 Mimetics Target Chemotherapy-Induced Senescent Cells in

  2026-04-26

  This study demonstrates that BH3 mimetics, which inhibit anti-apoptotic Bcl-2 family proteins, can selectively eliminate chemotherapy-induced senescent tumor cells in TP53 wild-type breast cancer. The findings suggest a new therapeutic approach to improve outcomes by clearing residual senescent cells that promote relapse.

• EdU Imaging Kits (Cy3): Precision S-Phase Detection in Cance

  2026-04-25

  EdU Imaging Kits (Cy3) empower researchers with fast, denaturation-free S-phase detection, enabling high-sensitivity cell proliferation assays for cancer and genotoxicity studies. With optimized click chemistry, these kits surpass traditional BrdU methods in preserving cellular integrity and workflow simplicity.

• Hesperadin: Precision Aurora B Kinase Inhibition for Mitotic

  2026-04-24

  Hesperadin from APExBIO empowers precise, ATP-competitive inhibition of Aurora B kinase, redefining spindle assembly checkpoint studies and mitotic progression analyses. Its robust phenotypic outcomes and reproducible workflows make it a premier tool for cancer research and mechanistic dissection of chromosome segregation.

• Alfuzosin HCl in BPH: Clinical Review of Uroselective α1 Ant

  2026-04-24

  This article analyzes the clinical review by Mary Lee on alfuzosin hydrochloride for benign prostatic hyperplasia (BPH), highlighting its functionally uroselective α1-adrenergic antagonism, efficacy in lower urinary tract symptom relief, and favorable cardiovascular safety. The review details protocol-relevant dosing, mechanistic rationale, and practical implications for translational and preclinical BPH research.

• Integrating High-Throughput Screens for Mycobacterial DHFR I

  2026-04-23

  This study introduces a combined high-throughput screening and machine learning framework to identify mechanisms of action and novel inhibitors targeting Mycobacterium tuberculosis dihydrofolate reductase (DHFR). The methodology bridges the gap between phenotypic and target-based discovery, offering a scalable strategy for antibacterial development and precise MoA elucidation.

• Technical Use of Angiotensin I/II (1-5) in RAS Research

  2026-04-23

  Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide fragment for precise modeling of the renin-angiotensin system in hypertension and renal workflows. It is not suitable for unrelated peptide signaling studies due to its specific mechanistic and solubility profile.

• Dextrose (D-glucose) in Tumor Immunometabolism Research

  2026-04-22

  Dextrose (D-glucose) is a cornerstone reagent for dissecting glucose-driven metabolic reprogramming in hypoxic tumor microenvironments. This article delivers protocol-centric guidance, troubleshooting strategies, and translational insights, enabling researchers to harness APExBIO’s high-purity Dextrose for advanced metabolic and immunometabolic investigations.

• Tunicamycin as a Strategic Lever for Translational UPR Resea

  2026-04-22

  This article provides mechanistic and strategic guidance for translational researchers seeking to leverage Tunicamycin, a gold-standard N-glycosylation inhibitor, to dissect endoplasmic reticulum (ER) stress, inflammation, and protein homeostasis pathways. Building on recent findings in cadmium resistance and UPR modulation, it offers evidence-based protocol recommendations, positions Tunicamycin within the competitive landscape, and outlines the translational significance of precise ER stress modulation in disease models.

15360 records 1/1024 page Next 12345 下5页 Last page